Altogether, these results suggest that the enhanced immunoregulatory properties of human AD-MSC treated with PP11 or GSK3787 compared to naïve MSC or GSK3787 are associated with the higher expression of ANGPTL4 and COX2 and the higher activity of IDO. The gene discussed is ENDOU; the disease is Alzheimer disease.